The Hong Kong International Biotechnology Exhibition 2022 (BIOHK2022), held in Hong Kong from 14-17 Dec 2022, is an international conference co-organized by the Hong Kong Association of Biotechnology, BayHelix Group and Ausvic Capital, with the aim of providing a global networking platform for exploring Hong Kong's potentially unlimited biotechnology business opportunities and allowing industry players from all over the world to make connections. BIOHK 2022 consists of three events - an exhibition, academic presentations and project exchange sessions, and one-on-one business opportunities negotiation.

Apc001, jointly developed by Law Sau Fai Institute for Advancing Translational Medicine in Bone&Joint Diseases (TMBJ), Hong Kong Baptist University (HKBU) and Aptacure, which was exhibited at BIOHK 2022. Dr. Luyao Wang was invited to give an academic speech on behalf of the joint R&D team, introducing the R&D process of Apc001, which gained wide attention from the academic and investment communities.

Dr. Luyao Wang was invited to give an academic talk at BIOHK2022